Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sequential polydepsipeptides as biodegradable carriers for drug delivery systems.

M Yoshida1, M Asano, M Kumakura

  • 1Department of Development, Takasaki Radiation Chemistry Research Establishment, Japan.

Journal of Biomedical Materials Research
|September 1, 1990
PubMed
Summary

Biodegradable polymers, poly[(Ala)n-Glu(OEt)-Lac], show tunable degradation rates influenced by alanine units. The poly(Ala-Ala-Glu(OEt)-Lac) carrier demonstrated optimal degradation and sustained release of a luteinizing-hormone-releasing hormone agonist.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intervention of somatic mutational events in vivo by a germline defect at the adenine phosphoribosyltransferase locus.

Human genetics·1997
Same author

[Effects of alcohol on urate metabolism].

Nihon rinsho. Japanese journal of clinical medicine·1997
Same author

[A case report of renal cell carcinoma with bilateral adrenal metastases].

Hinyokika kiyo. Acta urologica Japonica·1997
Same author

An asymptomatic germline missense base substitution in the hypoxanthine phosphoribosyltransferase (HPRT) gene that reduces the amount of enzyme in humans.

Human genetics·1997
Same author

Generation and molecular characterisation of monoclonal IgG4 rheumatoid factor from a patient with rheumatoid arthritis.

Annals of the rheumatic diseases·1997
Same author

[How to select and use urate lowering agents for hyperuricemia].

Nihon rinsho. Japanese journal of clinical medicine·1996

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Drug Delivery Systems

Background:

  • Sequential polydepsipeptides, poly[(Ala)n-Glu(OEt)-Lac], containing peptide and ester bonds were synthesized.
  • These polymers are designed as biodegradable carriers for advanced drug delivery applications.

Purpose of the Study:

  • To evaluate the in vivo degradation of poly[(Ala)n-Glu(OEt)-Lac] polymers.
  • To assess the drug release profile of a luteinizing-hormone-releasing hormone (LH-RH) agonist incorporated into these polymer carriers.

Main Methods:

  • Subcutaneous implantation of polymers in male rats to assess in vivo degradation.
  • Incorporation of LH-RH agonist into poly(Ala-Ala-Glu(OEt)-Lac) using melt-pressing.
  • Analysis of drug release kinetics from blend-type and sandwich-type formulations.

Related Experiment Videos

Main Results:

  • Degradation rate was significantly influenced by the number of alanine (Ala) units; poly(Ala-Ala-Glu(OEt)-Lac) exhibited the highest degradability, achieving 100% degradation within 24 weeks.
  • Melt-pressing yielded cylindrical formulations with distinct drug dispersion patterns (blend-type and sandwich-type).
  • Blend-type formulations released the LH-RH agonist linearly over 6 weeks, while sandwich-type formulations maintained a constant release rate for 16 weeks.

Conclusions:

  • The number of alanine units in poly[(Ala)n-Glu(OEt)-Lac] critically controls in vivo degradation, with poly(Ala-Ala-Glu(OEt)-Lac) being highly degradable.
  • Poly(Ala-Ala-Glu(OEt)-Lac) carriers can be fabricated to control the release kinetics of incorporated drugs like the LH-RH agonist.
  • These findings highlight the potential of tailored polydepsipeptides for controlled and sustained drug delivery systems.